Supernus Wearable Device for Dosing Parkinson’s Drug Lands Long-Awaited FDA Approval

Supernus Pharmaceuticals’ Onapgo provides a continuous infusion of apomorphine to manage “off” periods experienced by Parkinson’s disease patients. Approval of Onapgo comes after the FDA twice turned back applications for the drug/device combination product. The post Supernus Wearable Device for Dosing Parkinson’s Drug Lands Long-Awaited FDA Approval appeared first on MedCity News.

Read More

Understanding the Intersection of Medicaid and Work: An Update

Amid renewed interest in Medicaid work requirements as part of a broader legislative package designed to significantly reduce federal Medicaid spending, KFF has updated its analysis of the work status and demographic characteristics of Medicaid enrollees with the latest data. Data show that, in 2023, 92% of Medicaid adults were either working full or part-time…

Read More

The Future of Training: How Virtual Reality Can Protect Clinicians from Healthcare-associated Infections

VR allows learners to actually ‘see’ the virtual germs responsible for causing infections and spreading disease, which could otherwise only be seen under a microscope. The technology also heightens users’ senses, drawing their attention to things they would be unable to see in traditional learning environments.  The post The Future of Training: How Virtual Reality…

Read More